Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > A critical review of definitions used to describe Pseudomonas aeruginosa microbiological status in patients with Cystic Fibrosis for application in clinical trials

A critical review of definitions used to describe Pseudomonas aeruginosa microbiological status in patients with Cystic Fibrosis for application in clinical trials

Resource Type

CF Research News

Authors

Taccetti G; Denton M; Hayes K, ECFS-CTN Microbiology Group; Drevinek P and Sermet-Gaudelus I.

References

J Cyst Fibros. 2019 Sep 13. pii: S1569-1993(19)30867-7. doi: 10.1016/j.jcf.2019.08.014.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

Microbiological status [3]
Pseudomonas aeruginosa [4]
Serology [5]
anti pa-antibodies [6]

Date

Friday, September 13, 2019

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [7]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/critical-review-definitions-used-describe-pseudomonas-aeruginosa

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-19-00190R1_FINAL_Taccetti_121019.pdf [2] https://www.ncbi.nlm.nih.gov/pubmed/?term=A%20critical%20review%20of%20definitions%20used%20to%20describe%20Pseudomonas%20aeruginosa%20microbiological%20status%20in%20patients%20with%20Cystic%20Fibrosis%20for%20application%20in%20clinical%20trials [3] https://www.ecfs.eu/research-article-keywords/microbiological-status [4] https://www.ecfs.eu/research-article-keywords/pseudomonas-aeruginosa [5] https://www.ecfs.eu/research-article-keywords/serology [6] https://www.ecfs.eu/research-article-keywords/anti-pa-antibodies [7] https://www.ecfs.eu/resource-guideline-type/other-guidelines